Fatty Liver Disease Is Rising in Non-Drinking Indians: Causes, Risks, and What to Do
The numbers are not small
A 2023 meta-analysis published in the Journal of Clinical and Experimental Hepatology estimated NAFLD prevalence in India at approximately 38.6% of the general population, higher than the global average, and climbing fastest among people in their thirties and forties who report zero alcohol consumption. The condition has a newer name now: MAFLD, metabolic-associated fatty liver disease, a label that drops the word "non-alcoholic" entirely because researchers concluded that alcohol was never the central variable. Fat accumulates in liver cells when the organ is overwhelmed by metabolic load. Drinking accelerates that process. So does everything else about the way most urban Indians eat and move.
What maida and white rice are actually doing
The liver processes all dietary carbohydrates that arrive from the gut. When glucose enters the bloodstream faster than muscle and brain tissue can absorb it, the liver converts the excess into triglycerides and stores them as fat. Refined flour, maida in rotis, biscuits, white bread, and most packaged snacks, digests faster than the body can clear it. White rice eaten in large portions at lunch and dinner produces the same spike. Over months and years, the liver accumulates fat in its cells, a condition called hepatic steatosis. At this stage there is no pain, no jaundice, no obvious signal. Most people find out during an ultrasound ordered for an unrelated complaint.
The problem is not carbohydrates as a category. Traditional Indian diets built around millets, legumes, and whole grains digest slowly and give the liver time to manage the glucose load. The shift happened when refined grain products became cheaper and more convenient than whole-grain alternatives, a change that accelerated through the 1990s and 2000s as processed food distribution reached tier-two and tier-three cities.
Desk jobs and visceral fat
Skeletal muscle is the body's largest consumer of blood glucose. When muscle is active, it pulls glucose out of circulation without requiring insulin. When a person sits for eight to ten hours a day, a standard workday for IT professionals in Bengaluru, Pune, or Hyderabad, muscle uptake drops sharply. The same carbohydrate load that a moderately active person handles without incident becomes excess for someone sedentary. That excess routes to the liver.
Visceral fat, the fat stored around abdominal organs rather than under the skin, is metabolically active in a way subcutaneous fat is not. It releases free fatty acids directly into the portal vein, which drains straight into the liver. Indian adults tend to accumulate visceral fat at lower BMI thresholds than European populations, a pattern documented in research from the All India Institute of Medical Sciences, which found significant metabolic risk in Indian adults with BMI values that Western guidelines classify as normal. A person who appears lean by standard measures can still carry enough visceral fat to drive fatty liver disease.
Insulin resistance is the engine
Fatty liver and insulin resistance feed each other in a cycle that is difficult to interrupt once established. When liver cells are already fat-laden, they respond poorly to insulin signals. The pancreas compensates by producing more insulin. High circulating insulin tells fat cells to keep releasing fatty acids and tells the liver to keep synthesising fat from glucose. The liver gets worse. Insulin sensitivity drops further. A 2022 study in Diabetes & Metabolic Syndrome: Clinical Research & Reviews found that Indian patients with NAFLD had significantly higher fasting insulin levels and HOMA-IR scores, a standard measure of insulin resistance, compared to matched controls without liver fat, even after adjusting for BMI.
This is why fatty liver in non-drinkers is fundamentally a glucose and insulin story. The liver is downstream of every meal. When blood sugar management is poor, the liver absorbs the consequences.
What actually changes the trajectory
There is no approved drug for NAFLD or MAFLD. The clinical evidence points to two interventions with consistent results: reducing refined carbohydrate intake and increasing physical activity. A 7 to 10% reduction in body weight, achieved through diet rather than exercise alone, has been shown in multiple trials to significantly reduce hepatic fat content as measured by MRI. Replacing maida-based foods with jowar, bajra, or whole wheat reduces the glycaemic load of meals. Replacing a sedentary afternoon with a 30-minute walk after lunch improves postprandial glucose clearance and reduces the insulin burden on the liver over time.
Periodic liver function tests and an abdominal ultrasound are the standard screening tools. An ALT (alanine aminotransferase) level persistently above 40 U/L in the absence of alcohol use is a signal worth investigating. Most general physicians in India now include it in routine health panels, but many patients still do not follow up on mildly elevated results because there is no pain to prompt urgency.
The liver's silence is the disease's most dangerous feature. By the time NAFLD progresses to NASH, non-alcoholic steatohepatitis, where inflammation joins fat accumulation, and then to fibrosis, the window for dietary reversal has narrowed considerably. The disease is not irreversible at the fibrosis stage, but it is far harder to turn around than it was a decade earlier, when the only sign was a slightly bright liver on an ultrasound that the patient filed away and forgot.